Aptinyx to Present at the 40th Annual J.P. Morgan Healthcare Conference
13 December 2021 - 11:49PM
Business Wire
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical
company developing transformative therapies for the treatment of
brain and nervous system disorders, today announced that Andy Kidd,
M.D., president & chief executive officer, will present at the
40th Annual J.P. Morgan Healthcare Conference. The presentation
will take place on Thursday, January 13, 2022 at 12:00 p.m. Pacific
Time at the Westin St. Francis Hotel in San Francisco,
California.
A live webcast of the presentation will be available to view on
the “Events and Presentations” page in the “Investors & Media”
section of Aptinyx’s website at https://ir.aptinyx.com and will be
archived on Aptinyx’s website for 30 days following the event.
About Aptinyx
Aptinyx Inc. is a clinical-stage biopharmaceutical company
focused on the discovery, development, and commercialization of
proprietary synthetic small molecules for the treatment of brain
and nervous system disorders. Aptinyx has a platform for discovery
of novel compounds that work through a unique mechanism to
modulate—rather than block or over-activate—NMDA receptors and
enhance synaptic plasticity, the foundation of neural cell
communication. The company has three product candidates in clinical
development in central nervous system indications, including
chronic pain, post-traumatic stress disorder, and cognitive
impairment. Aptinyx is also advancing additional compounds from its
proprietary discovery platform, which continues to generate a rich
and diverse pipeline of small-molecule NMDA receptor modulators
with the potential to treat an array of neurologic disorders. For
more information, visit www.aptinyx.com.
Source: Aptinyx Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211213005151/en/
Patrick Flavin Aptinyx Inc. ir@aptinyx.com or
corporate@aptinyx.com 847-871-0377
Aptinyx (NASDAQ:APTX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Aptinyx (NASDAQ:APTX)
Historical Stock Chart
From Mar 2023 to Mar 2024